Country for PR: United States
Contributor: PR Newswire New York
Wednesday, November 16 2022 - 06:29
YC and Alchemist-backed Segmed Raises $5.2M Funding Round and Launches Medical Real World Imaging Platform 
PALO ALTO, Calif., Nov. 16, 2022 /PRNewswire-AsiaNet/ --

Segmed - a cloud-based real-world imaging platform that accelerates innovation 
in healthcare by simplifying access to medical data - announced the closing of 
a $5.2 million seed+ funding round led by Nina Capital, with participation from 
iGan Partners, M3 Inc, Mighty Capital, Expeditions Fund, and Alchemist 
Accelerator, bringing total funds raised to more than $10 million. The company 
also reported the launch of Segmed Insight.

Logo -

Segmed Insight was built with the goal of getting high-quality, real-world 
medical imaging datasets in the hands of clinicians, researchers and 
developers; particularly those seeking to train or validate their AI algorithms.

Medical researchers and AI developers using Segmed Insight can conduct a 
search, view studies and reports matching their search criteria, and construct 
datasets specific to their parameters. After placing an order, users receive 
data in hand within days - a process that took years prior to Segmed.

By forging partnerships with healthcare systems, hospitals and imaging clinics 
across 1,000 locations on 5 continents, Segmed has done the heavy lifting when 
it comes to aggregating diverse medical data.

Patient privacy and data stewardship remain paramount at Segmed. The company 
maintains strict HIPAA/GDPR compliance, obtained its SOC2 attestation this 
year, and only shares fully de-identified data, ensuring that no personal 
information is exposed.

"The healthcare industry has become increasingly adoptive of artificial 
intelligence methods, but a roadblock in the development of unbiased, 
high-performing algorithms has been the timely acquisition of diverse, 
high-quality data," said Dr. Martin Willemink, CEO and co-founder at Segmed. 
"With Insight, our customers can massively cut down on data sourcing time, 
which in turn accelerates research and development in the medical field."

"Segmed is well positioned to lower the barriers for innovation in medical AI 
by bridging the gap between data providers and data consumers," said Sebastian 
Anastassiou, Head of Investments at Nina Capital. "This will make it easier to 
tackle tough healthcare problems, ultimately improving the quality of patient 
care in years to come."

"We are excited to be supporting Segmed in their latest raise – we believe that 
the company is on a growth trajectory to becoming one of the leading AI data 
platforms in the healthcare industry. They have real time access to 
machine-readable data with a focus on medical imaging, which is an invaluable 
type of data for healthcare. With this round, iGan is looking forward to 
working with Martin and the team to drive outbound partnerships and expand key 
features of the platform." said Sam Ifergan, Managing Partner at iGan Partners.

About Segmed

By partnering with global healthcare providers; standardizing and 
de-identifying data via a sequence of proprietary algorithms; and allowing 
users to build customized datasets, Segmed has become a one-stop-shop for rapid 
medical data aggregation. To learn more, visit [ 
] or get started at [ 
SOURCE: Segmed